Platelets in equine recurrent airway obstruction
Authors: Hammond A., Bailey S.R., Marr C.M., Cunningham F.M.
Journal: Research in Veterinary Science
Summary
# Editorial Summary: Platelets in Equine Recurrent Airway Obstruction Recurrent airway obstruction (RAO) in mature horses involves both neutrophilic airway inflammation and systemic activation of circulating platelets and neutrophils, yet the practical utility of measuring these cellular changes remained unclear. Hammond and colleagues established flow cytometric protocols to track activation markers (CD13 on neutrophils; CD41/61 and CD62P on platelets) and heterotypic neutrophil-platelet aggregate formation before and after antigen challenge in RAO-affected and healthy horses, using in vitro activation studies to validate their measurements. RAO-positive horses showed significantly elevated CD13 expression on neutrophils at both 10 and 24 hours post-challenge, alongside increased platelet side scatter and enhanced thrombin-stimulated platelet adhesion at 24 hours, whereas healthy controls demonstrated no such changes. Whilst these findings confirm that circulating platelet activation occurs systemically in RAO, the absence of detectable changes in platelet activation marker expression or aggregate formation in vivo suggests that traditional flow cytometric markers may not reliably capture the functional platelet abnormalities present during disease. For equine practitioners, this work highlights CD13 expression as a potentially useful biomarker of neutrophil activation in RAO, but indicates that platelet involvement may require alternative assessment methods beyond standard activation markers if circulating platelet status is to inform clinical decision-making.
Read the full abstract on PubMed
Practical Takeaways
- •CD13 expression on circulating neutrophils may serve as a practical diagnostic or monitoring marker for RAO flare-ups, with measurable changes within 10-24 hours of antigen exposure
- •Platelet activation appears more complex than simple marker expression; functional adhesion assays may better reflect true platelet involvement in RAO than flow cytometric markers alone
- •The dissociation between in vitro platelet activation markers and in vivo findings suggests the blood environment in RAO horses creates conditions that activate platelets differently than laboratory stimulation
Key Findings
- •CD13 expression on neutrophils increased significantly at 10h and 24h post-antigen challenge in RAO horses but not controls
- •Platelet activation markers (CD41/61, CD62P) were detectable in vitro but did not change consistently post-challenge in vivo despite evidence of circulating platelet activation
- •In vitro neutrophil-platelet aggregates formed significantly following PAF activation of both cell types
- •Thrombin-stimulated platelet adhesion was elevated at 24h in RAO horses, indicating functional platelet activation despite lack of marker expression changes